First Page | Document Content | |
---|---|---|
Medicine Biology Food and Drug Administration Drug safety Pharmacology Articular cartilage repair Investigational New Drug New Drug Application Investigational Device Exemption Research Clinical research Pharmaceutical industry | SOPP 8002 Appendix 2 - Final GuidanceAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 156,52 KBShare Document on Facebook |
Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document | |
Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document | |
United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. SenateDocID: 1riEa - View Document | |
Microsoft Word - FINAL 10K2014-Cover Page final to printDocID: 1r76P - View Document | |
Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTSDocID: 1qZGZ - View Document |